Bausch Health Companies
BHC
$0.28 (-3.86%)
1D
1W
3M
1Y
5Y
ALL
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health, gastroenterology (GI), and dermatology, a range of branded, generic and branded generic pharmaceuticals, over the counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries. The Company operates through five segments: Bausch + Lomb, Salix, International, Solta Medical, and Diversified Products. The Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, Consumer, Surgical, and Ophthalmic Pharmaceuticals products. The Salix segment consists of sales in the United States of gastrointestinal (GI) products. The Solta Medical segment consists of global sales of Solta aesthetic medical devices.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
GlobeNewsWire • 6 days ago • BHC
Bausch + Lomb Corporation Investigated by the Portnoy Law Firm
PRNewsWire • 24 days ago • BHC
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
Zacks Investment Research • 27 days ago • BHC
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?
Seeking Alpha • 28 days ago • BHC
Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats
Zacks Investment Research • 28 days ago • BHC
BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.